Annual EBITDA:
$233.41M+$11.90M(+5.37%)Summary
- As of today, HRMY annual EBITDA is $233.41 million, with the most recent change of +$11.90 million (+5.37%) on December 31, 2024.
- During the last 3 years, HRMY annual EBITDA has risen by +$152.95 million (+190.09%).
- HRMY annual EBITDA is now at all-time high.
Performance
HRMY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$59.25M-$7.73M(-11.54%)Summary
- As of today, HRMY quarterly EBITDA is $59.25 million, with the most recent change of -$7.73 million (-11.54%) on June 30, 2025.
- Over the past year, HRMY quarterly EBITDA has increased by +$27.10 million (+84.29%).
- HRMY quarterly EBITDA is now -18.26% below its all-time high of $72.49 million, reached on September 30, 2024.
Performance
HRMY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$265.05M+$27.10M(+11.39%)Summary
- As of today, HRMY TTM EBITDA is $265.05 million, with the most recent change of +$27.10 million (+11.39%) on June 30, 2025.
- Over the past year, HRMY TTM EBITDA has increased by +$54.90 million (+26.12%).
- HRMY TTM EBITDA is now at all-time high.
Performance
HRMY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HRMY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +5.4% | +84.3% | +26.1% |
| 3Y3 Years | +190.1% | +51.1% | +152.0% |
| 5Y5 Years | +263.6% | +536.2% | +1587.9% |
HRMY EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +190.1% | -18.3% | +228.8% | at high | +114.4% |
| 5Y | 5-Year | at high | +263.6% | -18.3% | +536.7% | at high | +1587.9% |
| All-Time | All-Time | at high | +263.6% | -18.3% | +194.0% | at high | +332.6% |
HRMY EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $59.25M(-11.5%) | $265.05M(+11.4%) |
| Mar 2025 | - | $66.98M(+1.0%) | $237.95M(+1.9%) |
| Dec 2024 | $233.41M(+5.4%) | $66.33M(-8.5%) | $233.41M(+7.2%) |
| Sep 2024 | - | $72.49M(+125.5%) | $217.69M(+3.6%) |
| Jun 2024 | - | $32.15M(-48.5%) | $210.15M(-10.3%) |
| Mar 2024 | - | $62.44M(+23.4%) | $234.38M(+5.8%) |
| Dec 2023 | $221.51M(+50.8%) | $50.61M(-22.1%) | $221.51M(-2.8%) |
| Sep 2023 | - | $64.95M(+15.2%) | $227.78M(+25.9%) |
| Jun 2023 | - | $56.38M(+13.7%) | $180.85M(+10.5%) |
| Mar 2023 | - | $49.58M(-12.8%) | $163.69M(+11.5%) |
| Dec 2022 | $146.87M | $56.88M(+215.6%) | $146.87M(+18.8%) |
| Sep 2022 | - | $18.02M(-54.0%) | $123.63M(+17.5%) |
| Jun 2022 | - | $39.21M(+19.7%) | $105.19M(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $32.75M(-2.7%) | $94.02M(+16.9%) |
| Dec 2021 | $80.46M(+5218.0%) | $33.65M(+8091.9%) | $80.46M(+142.0%) |
| Sep 2021 | - | -$421.00K(-101.5%) | $33.25M(-27.7%) |
| Jun 2021 | - | $28.05M(+46.1%) | $46.02M(+68.7%) |
| Mar 2021 | - | $19.19M(+241.4%) | $27.28M(+7374.8%) |
| Dec 2020 | $1.51M(+101.1%) | -$13.57M(-209.9%) | $365.00K(+102.0%) |
| Sep 2020 | - | $12.35M(+32.6%) | -$17.81M(+40.9%) |
| Jun 2020 | - | $9.31M(+220.5%) | -$30.16M(+48.5%) |
| Mar 2020 | - | -$7.73M(+75.7%) | -$58.61M(+48.6%) |
| Dec 2019 | -$142.69M(-245.9%) | -$31.75M(-65.9%) | -$113.94M(-38.6%) |
| Jun 2019 | - | -$19.14M(+69.6%) | -$82.19M(-30.4%) |
| Mar 2019 | - | -$63.05M | -$63.05M |
| Dec 2018 | -$41.26M | - | - |
FAQ
- What is Harmony Biosciences Holdings, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. annual EBITDA year-on-year change?
- What is Harmony Biosciences Holdings, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. quarterly EBITDA year-on-year change?
- What is Harmony Biosciences Holdings, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. TTM EBITDA year-on-year change?
What is Harmony Biosciences Holdings, Inc. annual EBITDA?
The current annual EBITDA of HRMY is $233.41M
What is the all-time high annual EBITDA for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high annual EBITDA is $233.41M
What is Harmony Biosciences Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, HRMY annual EBITDA has changed by +$11.90M (+5.37%)
What is Harmony Biosciences Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of HRMY is $59.25M
What is the all-time high quarterly EBITDA for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high quarterly EBITDA is $72.49M
What is Harmony Biosciences Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, HRMY quarterly EBITDA has changed by +$27.10M (+84.29%)
What is Harmony Biosciences Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of HRMY is $265.05M
What is the all-time high TTM EBITDA for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high TTM EBITDA is $265.05M
What is Harmony Biosciences Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, HRMY TTM EBITDA has changed by +$54.90M (+26.12%)